Frequency of dendritic cell subsets and ILT3, ILT4 gene expression in two different immunosuppressive protocols in kidney transplant recipients. A cohort report-Reference-Cited by-同舟云学术

Frequency of dendritic cell subsets and ILT3, ILT4 gene expression in two different immunosuppressive protocols in kidney transplant recipients. A cohort report

Published:2019-12-13 Issue:1 Volume:47 Page:123-128
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Karimi Mozhdeh,Ahmadpoor Pedram,Nafar Mohsen,Pourrezagholi Fatemeh,Jamali Saeideh,Eteghadi Atefeh,Yekaninejad Mir Saeed,Amirzargar Ali Akbar

Funder

tehran university of medical sciences

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11033-019-05113-x.pdf

Reference21 articles.

1. Opelz G, Döhler B (2007) Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 84(2):137–143

2. Rosborough BR, Hackstein H, Turnquist HR (2014) A window into immunosuppressant immunoregulation: recipient conversion to rapamycin increases potentially tolerogenic immune cells. Kidney Int 85(4):743–745

3. Meier-Kriesche HU, Schold JD, Kaplan B (2004) Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transpl 4(8):1289–1295

4. Banchereau J et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18(1):767–811

5. Daniel V (2008) Dendritische Zellen und Immunsuppression nach Organtransplantation/Dendritic cells and immunosuppression after organ transplantation. LaboratoriumsMedizin 32(3):131–139

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets;Biomolecules;2024-02-04

2. Evaluation of Thymic Output and Regulatory T Cells in Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection;BioMed Research International;2021-02-09

3. Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer;Antibody Therapeutics;2021-01-01